LON:BTEK Holdings Information

LON:BTEK is an equity ETF with a total of 267 individual holdings. The top holdings are Gilead Sciences stock at 7.73%, Amgen at 7.49%, Vertex Pharmaceuticals at 7.42%, Regeneron Pharmaceuticals at 6.44%, and Alnylam Pharmaceuticals at 3.52%.

Total Holdings

267

Top 10 Percentage

42.99%

Asset Class

Equity

ETF Category

Health Care

Assets

649.29M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.73%	517,400
2	AMGN	Amgen Inc.	7.49%	198,548
3	VRTX	Vertex Pharmaceuticals Incorporated	7.42%	155,111
4	REGN	Regeneron Pharmaceuticals, Inc.	6.44%	77,817
5	ALNY	Alnylam Pharmaceuticals, Inc.	3.52%	99,326
6	INSM	Insmed Incorporated	2.83%	161,427
7	BIIB	Biogen Inc.	2.16%	109,914
8	UTHR	United Therapeutics Corporation	2.09%	32,821
9	ARGX	argenx SE	1.66%	21,234
10	RPRX	Royalty Pharma plc	1.65%	321,547
11	MRNA	Moderna, Inc.	1.61%	295,774
12	ROIV	Roivant Sciences Ltd.	1.59%	537,138
13	RVMD	Revolution Medicines, Inc.	1.55%	148,416
14	ILMN	Illumina, Inc.	1.51%	114,405
15	INCY	Incyte Corporation	1.50%	149,040
16	VTRS	Viatris Inc.	1.25%	862,289
17	SMMT	Summit Therapeutics Inc.	1.18%	580,687
18	BBIO	BridgeBio Pharma, Inc.	1.16%	145,711
19	ASND	Ascendis Pharma A/S	1.13%	46,066
20	MEDP	Medpace Holdings, Inc.	1.09%	21,241
21	NBIX	Neurocrine Biosciences, Inc.	1.06%	75,099
22	IONS	Ionis Pharmaceuticals, Inc.	0.99%	123,602
23	GH	Guardant Health, Inc.	0.97%	98,145
24	MDGL	Madrigal Pharmaceuticals, Inc.	0.96%	17,166
25	SNY	Sanofi	0.95%	183,140

Showing 25 of 267 holdings

Subscribe to see the full list

Activate Now

As of Mar 31, 2026